Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function (TOPCAT)

Gender PreferenceNone
Age Group50 - 99 years
Research Start DateAugust 1, 2006
Research End DateJuly 31, 2013
Principal InvestigatorFrances Johnson, MD
Description

The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing all cause mortality in patients who have heart failure with preserved systolic function.

This study is closed to enrollment and in the follow-up phase.

Please refer to www.clinicaltrials.gov identifier NCT00094302 for more information.

Contact Info

Cardiomyopathy Treatment Program

Page Scovel, RN

phone:  319-356-1028

fax: 319-356-7087

email:  page-scovel@uiowa.edu

Keywordsspan itemProp='description'>Cardiac disease ; Cardiomyopathy ; CHF ; Congestive heart failure ; Diastolic dysfunction ; Heart ; Heart Failure ; Preserved systolic function ;